These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9735531)
1. Behavioral changes in autistic individuals as a result of wearing ambient transitional prism lenses. Kaplan M; Edelson SM; Seip JA Child Psychiatry Hum Dev; 1998; 29(1):65-76. PubMed ID: 9735531 [TBL] [Abstract][Full Text] [Related]
2. Postural orientation modifications in autism in response to ambient lenses. Kaplan M; Carmody DP; Gaydos A Child Psychiatry Hum Dev; 1996; 27(2):81-91. PubMed ID: 8936794 [TBL] [Abstract][Full Text] [Related]
3. Spatial orientation adjustments in children with autism in Hong Kong. Carmody DP; Kaplan M; Gaydos AM Child Psychiatry Hum Dev; 2001; 31(3):233-47. PubMed ID: 11196013 [TBL] [Abstract][Full Text] [Related]
4. The TEACCH strategy in mentally retarded children with autism: a multidimensional assessment. Pilot study. Treatment and Education of Autistic and Communication Handicapped children. Panerai S; Ferrante L; Caputo V J Autism Dev Disord; 1997 Jun; 27(3):345-7. PubMed ID: 9229266 [No Abstract] [Full Text] [Related]
5. Visual symptoms and compliance with spectacle wear in myopic children: double-masked comparison between progressive addition lenses and single vision lenses. Suemaru J; Hasebe S; Ohtsuki H Acta Med Okayama; 2008 Apr; 62(2):109-17. PubMed ID: 18464887 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Handen BL; Johnson CR; Lubetsky M J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460 [TBL] [Abstract][Full Text] [Related]
7. Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study. Danfors T; von Knorring AL; Hartvig P; Langstrom B; Moulder R; Stromberg B; Torstenson R; Wester U; Watanabe Y; Eeg-Olofsson O J Clin Psychopharmacol; 2005 Oct; 25(5):485-9. PubMed ID: 16160627 [TBL] [Abstract][Full Text] [Related]
8. An android for enhancing social skills and emotion recognition in people with autism. Pioggia G; Igliozzi R; Ferro M; Ahluwalia A; Muratori F; De Rossi D IEEE Trans Neural Syst Rehabil Eng; 2005 Dec; 13(4):507-15. PubMed ID: 16425833 [TBL] [Abstract][Full Text] [Related]
9. Brief report: the effects of Tomatis sound therapy on language in children with autism. Corbett BA; Shickman K; Ferrer E J Autism Dev Disord; 2008 Mar; 38(3):562-6. PubMed ID: 17610057 [TBL] [Abstract][Full Text] [Related]
10. Effects of fenfluramine on autistic individuals residing in a state developmental center. Yarbrough E; Santat U; Perel I; Webster C; Lombardi R J Autism Dev Disord; 1987 Sep; 17(3):303-14. PubMed ID: 3308829 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. Bolman WM; Richmond JA J Autism Dev Disord; 1999 Jun; 29(3):191-4. PubMed ID: 10425581 [TBL] [Abstract][Full Text] [Related]
12. [Course of development in the second and third decades of life in patients with Kanner's syndrome. Results with special consideration of socially adaptive behavior]. Klosinski G; Troje AE Nervenarzt; 2004 Jul; 75(7):675-80. PubMed ID: 15300323 [TBL] [Abstract][Full Text] [Related]
13. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. Owley T; McMahon W; Cook EH; Laulhere T; South M; Mays LZ; Shernoff ES; Lainhart J; Modahl CB; Corsello C; Ozonoff S; Risi S; Lord C; Leventhal BL; Filipek PA J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1293-9. PubMed ID: 11699803 [TBL] [Abstract][Full Text] [Related]
14. [Infantile autism. Evaluation of cognitive and social disorders and therapeutic applications]. Adrien JL; Barthélémy C; Couturier G; Boiron M; Dansart P Soins Psychiatr; 1992; (140-141):21-6. PubMed ID: 1470943 [No Abstract] [Full Text] [Related]
15. Cognitive scripts in autistic children and adolescents. Volden J; Johnston J J Autism Dev Disord; 1999 Jun; 29(3):203-11. PubMed ID: 10425583 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of an intensive therapy program for treatment of severe behavioral disorders in mentally handicapped patients with autistic or psychotic behavior]. Elbing U; Rohmann UH Prax Kinderpsychol Kinderpsychiatr; 1993 Sep; 42(7):248-60. PubMed ID: 8248024 [TBL] [Abstract][Full Text] [Related]
17. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of porcine secretin in children with autism and pervasive developmental disorder. Kern JK; Van Miller S; Evans PA; Trivedi MH J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616 [TBL] [Abstract][Full Text] [Related]
19. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study. Willemsen-Swinkels SH; Buitelaar JK; van Engeland H Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837 [TBL] [Abstract][Full Text] [Related]
20. Use of methylphenidate in the treatment of children with autistic disorder. Quintana H; Birmaher B; Stedge D; Lennon S; Freed J; Bridge J; Greenhill L J Autism Dev Disord; 1995 Jun; 25(3):283-94. PubMed ID: 7559293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]